Skip to main content

and
  1. No Access

    Article

    In vivo detection of circulating tumor cells predicts high-risk features in patients with bladder cancer

    Previous studies have suggested the potential diagnostic value of circulating tumor cells (CTCs). This study aims to validate the efficacy of in vivo detection of CTCs in bladder cancer (BC) patients. A total ...

    Di **, Lei Qian, Jun **a, Ruiyun Zhang, Guoliang Yang, Lianhua Zhang in Medical Oncology (2023)

  2. No Access

    Article

    Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer

    To investigate the value of radiomics features from diffusion-weighted imaging (DWI) in differentiating muscle-invasive bladder cancer (MIBC) from non-muscle-invasive bladder cancer (NMIBC).

    Shuaishuai Xu, Qiuying Yao, Guiqin Liu, Di **, Haige Chen in European Radiology (2020)

  3. No Access

    Article

    Comprehensive genomic profiling of neuroendocrine bladder cancer pinpoints molecular origin and potential therapeutics

    Neuroendocrine bladder cancer is a relatively rare but often lethal malignancy, with cell of origin, oncogenomic architecture and standard treatment poorly defined. Here we performed comprehensive whole-genome...

    Peiye Shen, Ying **g, Ruiyun Zhang, Mei-Chun Cai, Pengfei Ma, Haige Chen in Oncogene (2018)

  4. No Access

    Article

    AEG-1 is associated with tumor progression in nonmuscle-invasive bladder cancer

    Astrocyte elevated gene-1 (AEG-1), a novel oncoprotein, has been implicated in oncogenesis and cancer progression in various types of human cancers. Here, immunohistochemistry was used to detect AEG-1 express...

    Guoliang Yang, Lianhua Zhang, Shilong Lin, Linfeng Li, Mengyao Liu in Medical Oncology (2014)